Vimarsana
Biggest News Aggregation in the World

World Leading Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from World Leading Platform. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In World Leading Platform Today - Breaking & Trending Today

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields - Vimarsana News

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields

2021年04月26日 11時42分 Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields Hong Kong, 2021年04月26日 - (JCN Newswire) - Scivita Medical Technology Co., Ltd. ("Scivita Medical") today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures, with ...

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives - Vimarsana News

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives

Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives Scivita Medical Raises Nearly RMB0.4 Billion in Series A Funding Round and Strives to Build A World-leading Platform for Innovative Products in Endoscope and Related Fields BriefingWire.com, 4/25/2021 - Scivita Medical Technology Co., Ltd. (Scivita Medical) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was...